Special population considerations and regulatory affairs for clinical research

about

Signal detection activity on EudraVigilance data: analysis of the procedure and findings from an Italian Regional Centre for Pharmacovigilance.Design and conduct of early phase drug studies in children: challenges and opportunities

P2860

Q31155016-57660FB1-E5DA-452A-BBFE-C74C87B523F0 Q38879907-ACE49359-A88F-43C7-BD55-FAC707BF35CF

P2860

Special population considerations and regulatory affairs for clinical research

Item

http://www.wikidata.org/entity/Q36078698

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Special population considerations and regulatory affairs for clinical research

@ast

Special population considerations and regulatory affairs for clinical research

@en

type

Item

label

Special population considerations and regulatory affairs for clinical research

@ast

Special population considerations and regulatory affairs for clinical research

@en

prefLabel

Special population considerations and regulatory affairs for clinical research

@ast

Special population considerations and regulatory affairs for clinical research

@en

P1476

Special population considerations and regulatory affairs for clinical research

@en

P2093

Athena F Zuppa

http://www.w3.org/2001/XMLSchema#string

Casey Tak

http://www.w3.org/2001/XMLSchema#string

Jonathan E Constance

http://www.w3.org/2001/XMLSchema#string

Kristin N Grimsrud

http://www.w3.org/2001/XMLSchema#string

Michael G Spigarelli

http://www.w3.org/2001/XMLSchema#string

Nicole L Mihalopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Neonatal clinical pharmacology

Trends in pregnancy labeling and data quality for US-approved pharmaceuticals.

Body composition during the first 2 years of life: an updated reference.

Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008.

Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity

Liver.

A simple estimate of glomerular filtration rate in full-term infants during the first year of life.

Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the Ethics Working Group of the Confederation of European Specialists in Paediatrics (CESP).

Liver function and phase I drug metabolism in the elderly: a paradox.

Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs.

P304

47-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10601333.2015.1001900

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Catherine M Sherwin

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26401094

http://www.w3.org/2001/XMLSchema#string

P932

4577021

http://www.w3.org/2001/XMLSchema#string

Special population considerations and regulatory affairs for clinical research

about

P2860

P2860

Special population considerations and regulatory affairs for clinical research

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932